Application of Epidural Infusion Port in the Treatment of Postherpetic Neuralgia

A retrospective observational study on the treatment of postherpetic neuralgia with epidural infusion port

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500108238

Enrollment

Unknown

Registered

2025-08-27

Start date

2025-09-01

Completion date

Unknown

Last updated

2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic Neuralgia

Interventions

late group:None

early group:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-80 years, no gender restriction; 2. Diagnosed with PHN; 3. Normal communication ability; 4. Complete follow-up data (>=3 months), received epidural infusion port treatment and signed the treatment consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with systemic or local skin infection at the puncture site; 2. Patients with severe cardiovascular or cerebrovascular diseases, or coagulation disorders; 3. Patients who have had recent surgery, trauma, are using immunosuppressants, or have malignancies, tuberculosis, or other infections.

Design outcomes

Primary

Measure	Time frame
visual analog scale score;	—

Secondary

Measure	Time frame
Pittsburgh sleep quality index score;Dosage of analgesic drugs;	—

Countries

China

Contacts

Public ContactHuacheng Zhou

The Fourth Affiliated Hospital of Harbin Medical University

zhouhuacheng@163.com+86 451 85939542

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026